These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39279440)

  • 1. Antitumor Effect of Oleoyl-siRNA against Pancreatic Cancer Using a Portal Vein Infusion Liver-Metastatic Mouse Model.
    Kubo T; Yanagihara K; Nishimura Y; Iino Y; Komatsu T; Tansou R; Mihara K; Seyama T
    Mol Pharm; 2024 Oct; 21(10):5115-5125. PubMed ID: 39279440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nek2 siRNA therapy using a portal venous port-catheter system for liver metastasis in pancreatic cancer.
    Kokuryo T; Hibino S; Suzuki K; Watanabe K; Yokoyama Y; Nagino M; Senga T; Hamaguchi M
    Cancer Sci; 2016 Sep; 107(9):1315-20. PubMed ID: 27316377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Administration of Small Interfering RNA Targeting Human Nestin Inhibits Pancreatic Cancer Cell Proliferation and Metastasis.
    Matsuda Y; Ishiwata T; Yoshimura H; Yamashita S; Ushijima T; Arai T
    Pancreas; 2016 Jan; 45(1):93-100. PubMed ID: 26335012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of palmitic acid-conjugated DsiRNA for colon cancer in a mouse subcutaneous tumor model.
    Kubo T; Nishimura Y; Hatori Y; Akagi R; Mihara K; Yanagihara K; Seyama T
    Chem Biol Drug Des; 2019 Apr; 93(4):570-581. PubMed ID: 30560565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Mol Cancer Ther; 2007 Mar; 6(3):833-43. PubMed ID: 17363479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.
    Ganesh S; Koser ML; Cyr WA; Chopda GR; Tao J; Shui X; Ying B; Chen D; Pandya P; Chipumuro E; Siddiquee Z; Craig K; Lai C; Dudek H; Monga SP; Wang W; Brown BD; Abrams MT
    Mol Cancer Ther; 2016 Sep; 15(9):2143-54. PubMed ID: 27390343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
    Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
    Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
    Dudek H; Wong DH; Arvan R; Shah A; Wortham K; Ying B; Diwanji R; Zhou W; Holmes B; Yang H; Cyr WA; Zhou Y; Shah A; Farkiwala R; Lee M; Li Y; Rettig GR; Collingwood MA; Basu SK; Behlke MA; Brown BD
    Mol Ther; 2014 Jan; 22(1):92-101. PubMed ID: 24089139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
    J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRH1 promotes pancreatic cancer metastasis.
    Lin Q; Aihara A; Chung W; Li Y; Chen X; Huang Z; Weng S; Carlson RI; Nadolny C; Wands JR; Dong X
    Cancer Lett; 2014 Aug; 350(1-2):15-24. PubMed ID: 24769073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
    Liu JP; Yuan SZ; Zhang SN
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA.
    Wang J; Ding W; Sun B; Jing R; Huang H; Shi G; Wang H
    Mol Cell Biochem; 2012 Apr; 363(1-2):1-10. PubMed ID: 22170570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells.
    Zhong Y; Xia Z; Liu J; Lin Y; Zan H
    Oncol Rep; 2012 Apr; 27(4):1003-10. PubMed ID: 22200969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of angiopoietin-2 suppresses metastasis in human pancreatic carcinoma by reduced matrix metalloproteinase-2.
    Zhang ZX; Zhou J; Zhang Y; Zhu DM; Li DC; Zhao H
    Mol Biotechnol; 2013 Mar; 53(3):336-44. PubMed ID: 22457202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
    Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
    Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
    Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
    Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.